Cybin Inc. (CYBN)
NYSEAMERICAN: CYBN · Real-Time Price · USD
8.24
+0.77 (10.31%)
May 27, 2025, 3:52 PM - Market open
Cybin Market Cap
Cybin has a market cap or net worth of $173.34 million as of May 27, 2025. Its market cap has decreased by -38.37% in one year.
Market Cap
173.34M
Enterprise Value
65.15M
1-Year Change
-38.37%
Ranking
Category
Stock Price
$8.24
Market Cap Chart
Since November 11, 2020, Cybin's market cap has increased from $91.10M to $173.34M, an increase of 90.28%. That is a compound annual growth rate of 15.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 23, 2025 | 157.14M | -10.93% |
| Dec 31, 2024 | 176.41M | 4.62% |
| Dec 29, 2023 | 168.63M | 199.71% |
| Dec 30, 2022 | 56.26M | -72.57% |
| Dec 31, 2021 | 205.14M | 4.86% |
| Dec 31, 2020 | 195.64M | 114.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 298.78B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 221.01B |
| AstraZeneca | 218.42B |